CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Research and Treatment. 2018;50(4):1226-1237.   Published online 2017 December 28    DOI: https://doi.org/10.4143/crt.2017.446

Excel Download

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Cancer Research and Treatment. 2018;50(4):1226-1237   Crossref logo
Link1 Link2 Link3

PO68 TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
The Breast. 2013;22:S43   Crossref logo
Link1 Link2

Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice
Thoracic Cancer. 2017;8(5):523-529   Crossref logo
Link1 Link2

Efficacy and Safety of Eribulin in Patients with HER2-Negative Metastatic Breast Cancer: Real Life Experience
The Breast. 2017;36:S53-S54   Crossref logo
Link1 Link2

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
Breast Cancer: Targets and Therapy. 2011;101   Crossref logo
Link1

Efficacy and Safety of Eribulin in Patients with Triple Negative Metastatic Breast Cancer: Real Life Experience
The Breast. 2017;36:S57-S58   Crossref logo
Link1 Link2

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
Breast Diseases: A Year Book Quarterly. 2014;25(4):326-327   Crossref logo
Link1 Link2

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
International Journal of Women's Health. 2015;47   Crossref logo
Link1

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
International Journal of Women's Health. 2015;403   Crossref logo
Link1

Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
The Breast. 2017;32:66-72   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.